Grantham, Mayo, Van Otterloo (GMO) 13F, Q2 2024
Jeremy Grantham · quarter ending 30 June 2024 · filed 13 August 2024 · SEC CIK 1352662
Common stock only: shares the fund reported owning at the quarter end, valued as filed.
Largest positions, Q2 2024
The 25 largest of 525 positions. Weights are against the whole filed book. Changes are in shares held, against the Q1 2024 filing.
| Company | Ticker | Value | % of book | vs Q1 2024 |
|---|---|---|---|---|
| MICROSOFT CORP | MSFT | $1.69B | 5.7% | +5% shares |
| APPLE INC | AAPL | $1.27B | 4.3% | +33% shares |
| ALPHABET INC | GOOGL | $1.26B | 4.3% | unchanged |
| META PLATFORMS INC | META | $1.11B | 3.8% | +8% shares |
| UNITEDHEALTH GROUP INC | UNH | $1.01B | 3.4% | +10% shares |
| JOHNSON & JOHNSON | JNJ | $880.52M | 3.0% | +25% shares |
| LAM RESEARCH CORP | $817.40M | 2.8% | +4% shares | |
| ORACLE CORP | ORCL | $803.80M | 2.7% | +3% shares |
| TEXAS INSTRS INC | TXN | $785.80M | 2.6% | +4% shares |
| COCA COLA CO | KO | $749.29M | 2.5% | +6% shares |
| ELEVANCE HEALTH INC | ELV | $731.44M | 2.5% | +8% shares |
| AMAZON COM INC | AMZN | $676.58M | 2.3% | -14% shares |
| MERCK & CO INC | MRK | $659.64M | 2.2% | +13% shares |
| INTUITIVE SURGICAL INC | ISRG | $633.61M | 2.1% | +4% shares |
| ACCENTURE PLC IRELAND | $616.75M | 2.1% | +8% shares | |
| ABBOTT LABS | ABT | $601.86M | 2.0% | +7% shares |
| TJX COS INC NEW | TJX | $596.14M | 2.0% | +4% shares |
| KLA CORP | KLAC | $572.04M | 1.9% | +5% shares |
| WELLS FARGO CO NEW | WFC | $566.51M | 1.9% | +7% shares |
| SALESFORCE INC | CRM | $544.45M | 1.8% | +7% shares |
| US BANCORP DEL | USB | $480.00M | 1.6% | +8% shares |
| OTIS WORLDWIDE CORP | OTIS | $466.02M | 1.6% | +4% shares |
| VISA INC | V | $461.73M | 1.6% | +7% shares |
| ELI LILLY & CO | LLY | $425.97M | 1.4% | -31% shares |
| CONSTELLATION BRANDS INC | STZ | $380.79M | 1.3% | +15% shares |
What changed since Q1 2024
Against the Q1 2024 filing, Grantham, Mayo, Van Otterloo (GMO) opened 80 new positions, added to 215, trimmed 153, left 77 unchanged and exited 68. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
New positions
- TMO$235.38M
- PR$171.68M
- CLS$38.50M
- CATALENT INC$26.25M
- SOLV$24.93M
- NXT$24.42M
- ORA$23.85M
- CEREVEL THERAPEUTICS HLDNG I$20.81M
and 72 more
Exited
- PIONEER NAT RES COwas $72.48M
- CELESTICA INCwas $57.11M
- CSIQwas $49.17M
- BTIwas $36.39M
- AERCAP HOLDINGS NVwas $34.22M
- MRNAwas $32.66M
- BRKRwas $24.95M
- SP PLUS CORPwas $20.80M
and 60 more
Other quarters
Source: SEC Form 13F-HR, accession 0001072613-24-000620, filed by Grantham, Mayo, Van Otterloo & Co. LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.